RM
Ramilaben Mahendrabhai Dave
About Ramilaben Mahendrabhai Dave
Data last updated:
Ramilaben Mahendrabhai Dave has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Lexmark Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lexmark Pharmaceuticals Private Limited at ₹7.76 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lexmark Pharmaceuticals Private Limited U24230GJ2013PTC077157 | Director | 10 Oct 2013 | 2013 | ₹7.76 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramilaben Mahendrabhai Dave
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramilaben Mahendrabhai Dave
Ramilaben Mahendrabhai Dave has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Lexmark Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Lexmark Pharmaceuticals Private Limited at ₹7.76 Cr (FY 2025).
Ramilaben Mahendrabhai Dave is associated with 1 company as Director, including Lexmark Pharmaceuticals Private Limited (₹7.76 Cr).
Ramilaben Mahendrabhai Dave has expertise in General Business.
Ramilaben Mahendrabhai Dave has 13 years in corporate governance.
By reported revenue, the largest current company of Ramilaben Mahendrabhai Dave is Lexmark Pharmaceuticals Private Limited, with revenue of ₹7.76 Cr (FY 2025).
Ramilaben Mahendrabhai Dave currently holds positions at 1 company: Lexmark Pharmaceuticals Private Limited (₹7.76 Cr).